Benjamin Seides, MD, Brings Advanced Interventional Pulmonology to NM
July 28, 2020 | 5 min. to read
Benjamin J. Seides, MD, NM Regional Medical Group interventional pulmonologist and director of Interventional Pulmonology at Central DuPage Hospital, is one of the first physicians in the U.S. to deploy the Auris Health Monarch™ Platform. This innovative robotic technology, which was installed at CDH in late 2019, holds the promise of leading the fight against lung cancer by facilitating earlier and more accurate diagnosis of lung nodules. The Monarch robot program at CDH is the first such offering at NM and just the second in the state of Illinois. Since the program launched less than a year ago, Dr. Seides and his team have performed almost 100 cases. The Monarch Platform is just one of several state-of-the-art, minimally invasive technologies that Dr. Seides and the NM Interventional Pulmonology team use for the diagnosis and treatment of benign and malignant diseases of the chest. Shortly after joining NM in July 2019, Dr. Seides was instrumental in bringing the new robotic technology to CDH, which is the only NM hospital to offer it. In August 2019, Dr. Seides also launched the Zephyr® Valve program at CDH, offering a minimally invasive treatment for emphysema that is producing great results. Today, the program at CDH is the fifth busiest of 150 centers nationwide.
CDH is also a site for several interventional pulmonology studies, including the multi-institutional TARGET study, which is examining the safety and efficacy of the Monarch platform, as well as a multi-institutional post-marketing registry examining the safety and efficacy of Zephyr valves. Dr. Seides also anticipates being involved with clinical trials of endobronchial therapeutics enabled by the Monarch, which are expected in the near future.
Dr. Seides is a board-certified interventional pulmonologist with training and additional American Board of Internal Medicine certification in internal medicine, pulmonary and critical care medicine. His clinical interests include minimally invasive advanced diagnostic and therapeutic approaches to benign and malignant diseases of the lung, pleura and thorax; complex airway disease; thoracic oncology; and endobronchial treatments for asthma and COPD.
“We want to create a world-class, state-of-the-art interventional pulmonology program that integrates seamlessly with our outstanding medical and radiation oncology, thoracic surgery, and radiology programs both here in the western suburbs and with our NM partners downtown,” Dr. Seides says. “Our goal is to provide the very best, evidence-based, minimally invasive care that modern medicine has to offer, close to where our patients live, and in a setting that is familiar and comfortable.”
Dr. Seides earned his medical degree from Tulane University School of Medicine, where he was elected to AOA, and he earned a Master of Public Health in health systems management from Tulane University School of Public Health and Tropical Medicine in New Orleans. He completed his residency in internal medicine, as well as his fellowship in pulmonary and critical care medicine, at New York University/Bellevue Hospital Centers. He went on to complete an advanced fellowship year in interventional pulmonology with Chicago Chest Center.
After spending several years practicing in Chicago, Dr. Seides moved with his family to be an assistant professor of medicine in interventional pulmonology at University of Wisconsin School of Medicine and Public Health. He returned to Chicago to join RMG as the medical director of Interventional Pulmonology.